USE OF GLP-1 RECEPTOR AGONISTS IN THE TREATMENT OF OBESITY: CLINICAL EVIDENCE AND NUTRITIONAL IMPLICATIONS. REMUNOM 2025, 21 (05), 1-11. https://doi.org/10.61164/dgpn4685.